Cobalt chloride hexahydrate
Common Name: |
Cobalt chloride hexahydrate |
IUPAC Name: |
cobalt(2+);dichloride;hexahydrate |
Molecular Formula: |
Cl2CoH12O6 |
SMILES: |
O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] |
Inchi: |
1S/2ClH.Co.6H2O/h2*1H;;6*1H2/q;;+2;;;;;;/p-2 |
Inchi Key: |
GFHNAMRJFCEERV-UHFFFAOYSA-L |
Cas No: |
7791-13-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
237.93 |
Mass (g/mol) |
236.934 |
Molar Refractivity |
29.99 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
0 |
Rings |
|
TPSA |
55.38 |
Hetero Atoms |
|
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
87 |
Boiling Point (°C@760.00mm Hg) |
100 |
Vapor Pressure (mmHg@25.00 °C) |
24.5 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
|
iLOGP |
2.42 |
XLOGP3 |
2.95 |
WLOGP |
2.36 |
MLOGP |
2.30 |
ESOL Log S |
-2.59 |
ESOL Solubility (mg/ml) |
0.398 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.04 |
Ali Solubility (mg/ml) |
0.14 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.49 |
Silicos-IT Solubility (mg/ml) |
5.05 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.15 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.326 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
-0.273 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |